153 related articles for article (PubMed ID: 37859901)
1. The Role of Matrix Metalloproteinase 13 and Vitamin D in Osteoarthritis: A Hospital-Based Observational Study.
Kumar P; Kumar S; Abhilasha A; Singh A; Kumar U
Cureus; 2023 Sep; 15(9):e45437. PubMed ID: 37859901
[TBL] [Abstract][Full Text] [Related]
2. A Preliminary Study of Combined Detection of COMP, TIMP-1, and MMP-3 in Synovial Fluid: Potential Indicators of Osteoarthritis Progression.
Plsikova Matejova J; Spakova T; Harvanova D; Lacko M; Filip V; Sepitka R; Mitro I; Rosocha J
Cartilage; 2021 Dec; 13(2_suppl):1421S-1430S. PubMed ID: 32748631
[TBL] [Abstract][Full Text] [Related]
3. Serum and knee synovial fluid matrix metalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late-stage osteoarthritis.
Özler K; Aktaş E; Atay Ç; Yılmaz B; Arıkan M; Güngör Ş
Acta Orthop Traumatol Turc; 2016; 50(3):356-61. PubMed ID: 27130394
[TBL] [Abstract][Full Text] [Related]
4. Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with generalized osteoarthritis.
Naito K; Takahashi M; Kushida K; Suzuki M; Ohishi T; Miura M; Inoue T; Nagano A
Rheumatology (Oxford); 1999 Jun; 38(6):510-5. PubMed ID: 10402070
[TBL] [Abstract][Full Text] [Related]
5. Synovial fluid levels of TWEAK and matrix metalloproteinase 1 in patients with osteoarthritis, and associations with disease severity.
Hwang IY; Youm YS; Cho SD; Choi SW; Bae MH; Park SJ; Kim HW
J Orthop Surg (Hong Kong); 2018; 26(1):2309499018760112. PubMed ID: 29486670
[TBL] [Abstract][Full Text] [Related]
6. Cartilage oligomeric protein, matrix metalloproteinase-3, and Coll2-1 as serum biomarkers in knee osteoarthritis: a cross-sectional study.
Georgiev T; Ivanova M; Kopchev A; Velikova T; Miloshov A; Kurteva E; Yuzeir K; Penkov M; Kabakchieva P; Rashkov R; Stoilov R
Rheumatol Int; 2018 May; 38(5):821-830. PubMed ID: 29164307
[TBL] [Abstract][Full Text] [Related]
7. Correlation Between Synovial Fluid Levels of Matrix Metalloproteinase's (MMP-1, MMP-3, and MMP-9) and TNF-α with the Severity of Osteoarthritis Knee in Rural Indian Population.
Kumar S; Kumar H; Mittal A; Singh PP; Yadav V; Kumar D; Ahmad I; Mishra V
Indian J Orthop; 2023 Oct; 57(10):1659-1666. PubMed ID: 37766944
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase protein expression profiles cannot distinguish between normal and early osteoarthritic synovial fluid.
Heard BJ; Martin L; Rattner JB; Frank CB; Hart DA; Krawetz R
BMC Musculoskelet Disord; 2012 Jul; 13():126. PubMed ID: 22824140
[TBL] [Abstract][Full Text] [Related]
9. Synovium-Synovial Fluid Axis in Osteoarthritis Pathology: A Key Regulator of the Cartilage Degradation Process.
Ingale D; Kulkarni P; Electricwala A; Moghe A; Kamyab S; Jagtap S; Martson A; Koks S; Harsulkar A
Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34209473
[TBL] [Abstract][Full Text] [Related]
10. Synovial Fluid Eotaxin-1 Levels May Reflect Disease Progression in Primary Knee Osteoarthritis Among Elderly Han Chinese: A Cross-Sectional Study.
Li B; Zhang YL; Yu SY
Cartilage; 2019 Oct; 10(4):408-416. PubMed ID: 29562767
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between osteopontin and cartilage oligomeric matrix protein levels in joint synovial fluid of patients with knee osteoarthritis and disease severity].
Li XY; Shen ZX; Yang D
Zhongguo Gu Shang; 2022 Jul; 35(7):655-60. PubMed ID: 35859377
[TBL] [Abstract][Full Text] [Related]
12. Serum and knee synovial fluid matrixmetalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late stage osteoarthritis.
Özler K; Aktaş E; Atay Ç; Yılmaz B; Arıkan M; Güngör Ş
Acta Orthop Traumatol Turc; 2016 Dec; 50(6):670-673. PubMed ID: 27932045
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-7 levels in synovial fluid increase with age and MMP-1 levels decrease with progression of osteoarthritis.
Rübenhagen R; Schüttrumpf JP; Stürmer KM; Frosch KH
Acta Orthop; 2012 Feb; 83(1):59-64. PubMed ID: 22206448
[TBL] [Abstract][Full Text] [Related]
14. Association of UCMA levels in serum and synovial fluid with severity of knee osteoarthritis.
Okuyan HM; Terzi MY; Ozcan O; Kalaci A
Int J Rheum Dis; 2019 Oct; 22(10):1884-1890. PubMed ID: 31424176
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase activity and prostaglandin E2 are elevated in the synovial fluid of meniscus tear patients.
Liu B; Goode AP; Carter TE; Utturkar GM; Huebner JL; Taylor DC; Moorman CT; Garrett WE; Kraus VB; Guilak F; DeFrate LE; McNulty AL
Connect Tissue Res; 2017; 58(3-4):305-316. PubMed ID: 27813662
[TBL] [Abstract][Full Text] [Related]
16. Correlation of fractalkine concentrations in serum and synovial fluid with the radiographic severity of knee osteoarthritis.
Zou Y; Li Y; Lu L; Lin Y; Liang W; Su Z; Wang X; Yang H; Wang J; Yu C; Huo L; Ye Y
Ann Clin Biochem; 2013 Nov; 50(Pt 6):571-5. PubMed ID: 23869024
[TBL] [Abstract][Full Text] [Related]
17. Associations of serum citrate levels with knee structural changes and cartilage enzymes in patients with knee osteoarthritis.
Bian F; Ruan G; Xu J; Wang K; Wu J; Ren J; Chang B; Ding C
Int J Rheum Dis; 2020 Mar; 23(3):435-442. PubMed ID: 31957331
[TBL] [Abstract][Full Text] [Related]
18. Synovial fluid biomarkers associated with osteoarthritis severity reflect macrophage and neutrophil related inflammation.
Haraden CA; Huebner JL; Hsueh MF; Li YJ; Kraus VB
Arthritis Res Ther; 2019 Jun; 21(1):146. PubMed ID: 31196179
[TBL] [Abstract][Full Text] [Related]
19. Association between hypoxia-inducible factor-1a levels in serum and synovial fluid with the radiographic severity of knee osteoarthritis.
Chu H; Xu ZM; Yu H; Zhu KJ; Huang H
Genet Mol Res; 2014 Dec; 13(4):10529-36. PubMed ID: 25511037
[TBL] [Abstract][Full Text] [Related]
20. Potential Value of Matrix Metalloproteinase-13 as a Biomarker for Osteoarthritis.
Xin X; Tan Q; Li F; Chen Z; Zhang K; Li F; Yang B; Xing Z; Zhou F; Tian Y; Lv Y; Zhu T
Front Surg; 2021; 8():750047. PubMed ID: 34778362
[No Abstract] [Full Text] [Related]
[Next] [New Search]
